Exosomal MicroRNA‐424‐5p From Polycystic Ovary Syndrome Follicular Fluid Attenuates Ovarian Inflammation via Targeting the Fibroblast Growth Factor 2/Fibroblast Growth Factor Receptor 1 Axis
Cell Biochemistry and Function · 2026
DOI: 10.1002/cbf.70248 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biochemistry and Function, 2026. Verfasst von Dong Yuan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: MicroRNAs, Polycystic Ovary Syndrome, Receptor, Fibroblast Growth Factor, Type 1, Follicular Fluid. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Chongqing Natural Science Foundation Committee, Postdoctoral Science Foundation Project, Chongqing Municipal Education Commission Foundation.
Abstract (Originalsprache)
Sustained low‐grade inflammation is increasingly recognized as a central element in how polycystic ovary syndrome (PCOS) develops. Here we set out to clarify what role follicular fluid (FF)‐borne exosomal miR‐424‐5p plays in shaping ovarian inflammation and how this ties in with the ovulatory problems seen in PCOS. Across FF samples taken from patients, miR‐424‐5p levels tracked inversely with pro‐inflammatory cytokine concentrations to a striking degree. When granulosa cells (GCs) were challenged with lipopolysaccharide (LPS), delivering exosomal miR‐424‐5p dampened cytokine release and restored the expression of ovulation‐linked genes. Using a dual‐luciferase reporter assay, we traced this effect to FGF2, which miR‐424‐5p binds directly, and we found FGF2/FGFR1 signaling to be conspicuously raised in PCOS. In dehydroepiandrosterone (DHEA)‐treated rats modeling the syndrome, giving exosomal miR‐424‐5p eased ovarian inflammation and brought back part of the lost ovulatory capacity. Taken together, the data suggest that exosomal miR‐424‐5p tempers ovarian inflammation in PCOS by holding the FGF2/FGFR1 axis in check, which casts fresh light on the follicular abnormalities that mark this condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Department of Pathology, College of Basic Medicine, Chongqing Medical University, Chongqing, China.
- Molecular Medicine Diagnostic and Testing Center, Chongqing Medical University, Chongqing, China.
- Department of Pathology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Department of Radiology, Chongqing General Hospital of the Chinese People's Armed Police Forces, Chongqing, China.
ORCID-Profile: Dong Yuan
Förderung
- Chongqing Natural Science Foundation Committee, Postdoctoral Science Foundation Project
- Chongqing Municipal Education Commission Foundation
Zitieren
APA
Yuan, D., Hao, X., Luo, J., Liu, Y., Du, P., & Yang, Z. (2026). Exosomal MicroRNA‐424‐5p From Polycystic Ovary Syndrome Follicular Fluid Attenuates Ovarian Inflammation via Targeting the Fibroblast Growth Factor 2/Fibroblast Growth Factor Receptor 1 Axis. Cell Biochemistry and Function. https://doi.org/10.1002/cbf.70248
Vancouver
Yuan D, Hao X, Luo J, Liu Y, Du P, Yang Z. Exosomal MicroRNA‐424‐5p From Polycystic Ovary Syndrome Follicular Fluid Attenuates Ovarian Inflammation via Targeting the Fibroblast Growth Factor 2/Fibroblast Growth Factor Receptor 1 Axis. Cell Biochemistry and Function. 2026. doi:10.1002/cbf.70248
BibTeX
@article{Yuan2026,
author = {Yuan, Dong and Hao, Xiaoming and Luo, Jing and Liu, Yi and Du, Pingjie and Yang, Zhu},
title = {Exosomal MicroRNA‐424‐5p From Polycystic Ovary Syndrome Follicular Fluid Attenuates Ovarian Inflammation via Targeting the Fibroblast Growth Factor 2/Fibroblast Growth Factor Receptor 1 Axis},
journal = {Cell Biochemistry and Function},
year = {2026},
doi = {10.1002/cbf.70248}
}
EUVIMED